Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Non-compliant with Nasdaq Listing Rule

NEW YORK (GenomeWeb News) – Accelrys said on Friday that it has been notified by Nasdaq that the company does not comply with a listing requirement that its audit committee be comprised of three independent directors.

The San Diego-based firm received written notification from Nasdaq on June 4, Accelrys said in a document filed with the US Securities and Exchange Commission. The non-compliance results from Kenneth Coleman's decision not to seek re-election to the company's board for personal reasons. Coleman is a member of Accelrys' audit committee and his decision leaves the firm short of Nasdaq's three-person requirement.

Accelrys has until the company's next shareholder meeting on May 30, 2014 to provide evidence to Nasdaq that it fulfills the listing requirement. If the shareholder meeting is held before Nov. 26, 2013, Accelrys has until that date to provide its evidence, though Accelrys said it doesn't have plans to hold its shareholder meeting before Nov. 26.

It is currently identifying candidates to replace Coleman, Accelrys said.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.